Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bowel (colorectal) cancer, Colon cancer, Rectal cancer
Closed
Phase 2
This trial is looking at a drug called etirinotecan pegol for bowel cancer that has spread to other parts of the body. It is for people who have a genetic change called a K-RAS .
Recruitment start: 1 August 2010
Recruitment end: 11 July 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Leslie Samuel
Experimental Cancer Medicine Centre (ECMC)
Nektar Therapeutics
Last reviewed: 17 October 2013
CRUK internal database number: 9336